研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

多组学分析揭示了DARS1-AS1/YBX1调控的转录后环路促进了胶质母细胞瘤的肿瘤发生与放射抗性。

Multiomics analyses reveal DARS1-AS1/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.

发表日期:2023 Aug 04
作者: Caishang Zheng, Yanjun Wei, Qiang Zhang, Ming Sun, Yunfei Wang, Jiakai Hou, Peng Zhang, Xiangdong Lv, Dan Su, Yujie Jiang, Joy Gumin, Nidhi Sahni, Baoli Hu, Wenyi Wang, Xi Chen, Daniel J McGrail, Chaolin Zhang, Suyun Huang, Han Xu, Junjie Chen, Frederick F Lang, Jian Hu, Yiwen Chen
来源: Cellular & Molecular Immunology

摘要:

胶质母细胞瘤(GBM)干细胞样细胞(GSCs)对于GBM的发生和治疗抗药性至关重要。越来越多的证据支持长链非编码RNA(lncRNAs)具有促进肿瘤功能,但它们在GSCs中的作用仍不明确。通过将CRISPRi筛选与多组学方法结合,我们发现了一个由lncRNA DARS1-AS1控制的转录后调控回路,促进了GBM细胞/GSCs的恶性特性。DARS1-AS1的耗竭抑制了GBM细胞/GSCs的增殖和GSCs的自我更新,延长了原位GBM模型的生存时间。DARS1-AS1耗竭还削弱了同源重组(HR)介导的双链断裂(DSB)修复,并增强了GBM细胞/GSCs的放射敏感性。在机制上,DARS1-AS1与YBX1相互作用,促进目标mRNA的结合和稳定化,形成一个混合的转录后调控正反馈环,上调了G1-S转换的关键调控因子的表达,包括E2F1和CCND1。DARS1-AS1/YBX1还稳定了FOXM1的mRNA,这是一个调控GSC自我更新和DSB修复的主要转录因子。我们的发现表明,DARS1-AS1/YBX1轴可能是GBM对放射治疗/HR缺陷靶向治疗敏感化的潜在治疗靶点。
The glioblastoma (GBM) stem cell-like cells (GSCs) are critical for tumorigenesis/therapeutic resistance of GBM. Mounting evidence supports tumor-promoting function of long noncoding RNAs (lncRNAs), but their role in GSCs remains poorly understood. By combining CRISPRi screen with orthogonal multiomics approaches, we identified a lncRNA DARS1-AS1-controlled posttranscriptional circuitry that promoted the malignant properties of GBM cells/GSCs. Depleting DARS1-AS1 inhibited the proliferation of GBM cells/GSCs and self-renewal of GSCs, prolonging survival in orthotopic GBM models. DARS1-AS1 depletion also impaired the homologous recombination (HR)-mediated double-strand break (DSB) repair and enhanced the radiosensitivity of GBM cells/GSCs. Mechanistically, DARS1-AS1 interacted with YBX1 to promote target mRNA binding and stabilization, forming a mixed transcriptional/posttranscriptional feed-forward loop to up-regulate expression of the key regulators of G1-S transition, including E2F1 and CCND1. DARS1-AS1/YBX1 also stabilized the mRNA of FOXM1, a master transcription factor regulating GSC self-renewal and DSB repair. Our findings suggest DARS1-AS1/YBX1 axis as a potential therapeutic target for sensitizing GBM to radiation/HR deficiency-targeted therapy.